LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 98

Search options

  1. Article ; Online: Primary immunodeficiencies and the control of Epstein-Barr virus infection.

    Palendira, Umaimainthan / Rickinson, Alan B

    Annals of the New York Academy of Sciences

    2015  Volume 1356, Page(s) 22–44

    Abstract: Human primary immunodeficiency (PID) states, where mutations in single immune system genes predispose individuals to certain infectious agents and not others, are experiments of nature that hold important lessons for the immunologist. The number of ... ...

    Abstract Human primary immunodeficiency (PID) states, where mutations in single immune system genes predispose individuals to certain infectious agents and not others, are experiments of nature that hold important lessons for the immunologist. The number of genetically defined PIDs is rising rapidly, as is the opportunity to learn from them. Epstein-Barr virus (EBV), a human herpesvirus, has long been of interest because of its complex interaction with the immune system. Thus, it causes both infectious mononucleosis (IM), an immunopathologic disease associated with exaggerated host responses, and at least one malignancy, EBV-positive lymphoproliferative disease, when those responses are impaired. Here, we describe the full range of PIDs currently linked with an increased risk of EBV-associated disease. These provide examples where IM-like immunopathology is fatally exaggerated, and others where responses impaired at the stage of induction, expansion, or effector function predispose to malignancy. Current evidence from this rapidly moving field supports the view that lesions in both natural killer cell and T cell function can lead to EBV pathology.
    MeSH term(s) Animals ; Burkitt Lymphoma/genetics ; Burkitt Lymphoma/immunology ; Burkitt Lymphoma/pathology ; Genetic Diseases, Inborn/genetics ; Genetic Diseases, Inborn/immunology ; Genetic Diseases, Inborn/pathology ; Herpesvirus 4, Human/immunology ; Humans ; Immunity, Cellular ; Immunologic Deficiency Syndromes/genetics ; Immunologic Deficiency Syndromes/immunology ; Immunologic Deficiency Syndromes/pathology ; Infectious Mononucleosis/genetics ; Infectious Mononucleosis/immunology ; Infectious Mononucleosis/pathology ; Killer Cells, Natural/immunology ; Killer Cells, Natural/pathology ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology
    Language English
    Publishing date 2015-09-28
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 211003-9
    ISSN 1749-6632 ; 0077-8923
    ISSN (online) 1749-6632
    ISSN 0077-8923
    DOI 10.1111/nyas.12937
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Emerging topics in human tumor virology.

    Masucci, Maria G / Rickinson, Alan B

    Seminars in cancer biology

    2014  Volume 26, Page(s) 1–3

    MeSH term(s) Animals ; Cell Transformation, Neoplastic ; Cell Transformation, Viral ; Humans ; Neoplasms/etiology ; Oncogenic Viruses/physiology ; Tumor Virus Infections/complications
    Language English
    Publishing date 2014-06
    Publishing country England
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 1033980-2
    ISSN 1096-3650 ; 1044-579X
    ISSN (online) 1096-3650
    ISSN 1044-579X
    DOI 10.1016/j.semcancer.2014.04.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Epstein-Barr virus-associated lymphomas.

    Shannon-Lowe, Claire / Rickinson, Alan B / Bell, Andrew I

    Philosophical transactions of the Royal Society of London. Series B, Biological sciences

    2017  Volume 372, Issue 1732

    Abstract: Epstein-Barr virus (EBV), originally discovered through its association with Burkitt lymphoma, is now aetiologically linked to a remarkably wide range of lymphoproliferative lesions and malignant lymphomas of B-, T- and NK-cell origin. Some occur as rare ...

    Abstract Epstein-Barr virus (EBV), originally discovered through its association with Burkitt lymphoma, is now aetiologically linked to a remarkably wide range of lymphoproliferative lesions and malignant lymphomas of B-, T- and NK-cell origin. Some occur as rare accidents of virus persistence in the B lymphoid system, while others arise as a result of viral entry into unnatural target cells. The early finding that EBV is a potent B-cell growth transforming agent hinted at a simple oncogenic mechanism by which this virus could promote lymphomagenesis. In reality, the pathogenesis of EBV-associated lymphomas involves a complex interplay between different patterns of viral gene expression and cellular genetic changes. Here we review recent developments in our understanding of EBV-associated lymphomagenesis in both the immunocompetent and immunocompromised host.This article is part of the themed issue 'Human oncogenic viruses'.
    MeSH term(s) Carcinogenesis ; Epstein-Barr Virus Infections/immunology ; Epstein-Barr Virus Infections/virology ; Herpesvirus 4, Human/physiology ; Humans ; Immunocompetence ; Immunocompromised Host ; Lymphoma/immunology ; Lymphoma/virology
    Language English
    Publishing date 2017-09-10
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 208382-6
    ISSN 1471-2970 ; 0080-4622 ; 0264-3839 ; 0962-8436
    ISSN (online) 1471-2970
    ISSN 0080-4622 ; 0264-3839 ; 0962-8436
    DOI 10.1098/rstb.2016.0271
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection.

    Forrest, Calum / Hislop, Andrew D / Rickinson, Alan B / Zuo, Jianmin

    PLoS pathogens

    2018  Volume 14, Issue 9, Page(s) e1007110

    Abstract: Human herpesviruses are antigenically rich agents that induce strong CD8+T cell responses in primary infection yet persist for life, continually challenging T cell memory through recurrent lytic replication and potentially influencing the spectrum of ... ...

    Abstract Human herpesviruses are antigenically rich agents that induce strong CD8+T cell responses in primary infection yet persist for life, continually challenging T cell memory through recurrent lytic replication and potentially influencing the spectrum of antigen-specific responses. Here we describe the first lytic proteome-wide analysis of CD8+ T cell responses to a gamma1-herpesvirus, Epstein-Barr virus (EBV), and the first such proteome-wide analysis of primary versus memory CD8+ T cell responses to any human herpesvirus. Primary effector preparations were generated directly from activated CD8+ T cells in the blood of infectious mononucleosis (IM) patients by in vitro mitogenic expansion. For memory preparations, EBV-specific cells in the blood of long-term virus carriers were first re-stimulated in vitro by autologous dendritic cells loaded with a lysate of lytically-infected cells, then expanded as for IM cells. Preparations from 7 donors of each type were screened against each of 70 EBV lytic cycle proteins in combination with the donor's individual HLA class I alleles. Multiple reactivities against immediate early (IE), early (E) and late (L) lytic cycle proteins, including many hitherto unrecognised targets, were detected in both contexts. Interestingly however, the two donor cohorts showed a different balance between IE, E and L reactivities. Primary responses targeted IE and a small group of E proteins preferentially, seemingly in line with their better presentation on the infected cell surface before later-expressed viral evasins take full hold. By contrast, target choice equilibrates in virus carriage with responses to key IE and E antigens still present but with responses to a select subset of L proteins now often prominent. We infer that, for EBV at least, long-term virus carriage with its low level virus replication and lytic antigen release is associated with a re-shaping of the virus-specific response.
    MeSH term(s) Antigens, Viral/immunology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/virology ; Carrier State/immunology ; Carrier State/virology ; Gene Expression/genetics ; Genes, Viral ; HLA Antigens/immunology ; Herpesvirus 4, Human/genetics ; Herpesvirus 4, Human/immunology ; Herpesvirus 4, Human/pathogenicity ; Host-Pathogen Interactions/immunology ; Humans ; Infectious Mononucleosis/immunology ; Infectious Mononucleosis/metabolism ; Infectious Mononucleosis/virology ; Proteome/immunology ; Proteome/metabolism
    Chemical Substances Antigens, Viral ; HLA Antigens ; Proteome
    Language English
    Publishing date 2018-09-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7374
    ISSN (online) 1553-7374
    ISSN 1553-7374
    DOI 10.1371/journal.ppat.1007110
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Epstein-Barr virus and infectious mononucleosis: what students can teach us.

    Rickinson, Alan B / Fox, Christopher P

    The Journal of infectious diseases

    2013  Volume 207, Issue 1, Page(s) 6–8

    MeSH term(s) Antibodies, Viral/blood ; Female ; Herpesvirus 4, Human/immunology ; Humans ; Infectious Mononucleosis/epidemiology ; Male
    Chemical Substances Antibodies, Viral
    Language English
    Publishing date 2013-01-01
    Publishing country United States
    Document type Comment ; Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jis647
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: EBV meets its match.

    Fox, Christopher P / Rickinson, Alan B

    Blood

    2010  Volume 115, Issue 5, Page(s) 920–921

    Language English
    Publishing date 2010-02-04
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2009-11-252437
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.

    Kelly, Gemma L / Rickinson, Alan B

    Hematology. American Society of Hematology. Education Program

    2007  , Page(s) 277–284

    Abstract: Burkitt lymphoma (BL), a tumor occurring in endemic, sporadic and AIDS-associated forms, is the classic example of a human malignancy whose pathogenesis involves a specific cellular genetic change, namely, a chromosomal translocation deregulating ... ...

    Abstract Burkitt lymphoma (BL), a tumor occurring in endemic, sporadic and AIDS-associated forms, is the classic example of a human malignancy whose pathogenesis involves a specific cellular genetic change, namely, a chromosomal translocation deregulating expression of the c-myc oncogene, complemented in many cases by the action of an oncogenic virus, the Epstein-Barr virus (EBV). Here we review recent work in two complementary areas of research: (1) on cellular genetic changes that occur in addition to the c-myc translocation in BL, in particular the capacity of p53/ ARF pathway breakage or of c-myc mutation to decouple the pro-proliferative effects of c-myc deregulation from its pro-apoptotic effects; and (2) on a postulated role for EBV in BL pathogenesis, through adopting restricted forms of virus latent gene expression that remain compatible with the c-myc-driven growth program but offer the tumor additional protection from apoptosis. We stress the many fundamental questions that remain to be resolved and, in that regard, highlight the general lessons that might be learned through understanding how two other infectious agents, malaria and HIV, dramatically enhance BL incidence.
    MeSH term(s) Burkitt Lymphoma/complications ; Burkitt Lymphoma/genetics ; Burkitt Lymphoma/pathology ; Burkitt Lymphoma/virology ; HIV Infections/complications ; Herpesvirus 4, Human/pathogenicity ; Humans ; Malaria/complications
    Language English
    Publishing date 2007
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ISSN 1520-4391
    ISSN 1520-4391
    DOI 10.1182/asheducation-2007.1.277
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Antigens and autophagy: the path less travelled?

    Taylor, Graham S / Rickinson, Alan B

    Autophagy

    2007  Volume 3, Issue 1, Page(s) 60–62

    Abstract: The Epstein-Barr virus (EBV)-coded nuclear antigen (EBNA) 1, a latent cycle protein endogenously expressed in EBV-transformed B lymphoblastoid cell lines (LCLs), is reported to be processed for CD4(+) T cell recognition by an intracellular route ... ...

    Abstract The Epstein-Barr virus (EBV)-coded nuclear antigen (EBNA) 1, a latent cycle protein endogenously expressed in EBV-transformed B lymphoblastoid cell lines (LCLs), is reported to be processed for CD4(+) T cell recognition by an intracellular route involving antigen delivery to the endosome/lyosome (MHC class II loading) compartment via macroautophagy. In contrast we find that, in the same cell type, two other virus-coded nuclear proteins of the latent cycle, EBNA2 and EBNA3C, are processed by a different route that is unaffected by autophagy inhibition. This involves the intercellular transfer of an antigenic moiety, detectable in cell-free culture supernatants, and its uptake and processing as exogenous antigen by neighboring cells. The process is cumulative and leads over several days of LCL culture to high levels of CD4+ T cell epitope display. The presentation of certain EBV lytic cycle proteins to CD4+ T cells has also recently been found to involve a similar intercellular antigen transfer. It becomes important to know why, even in the same cell type, some antigens but not others appear to access the MHC class II presentation pathway by autophagy.
    MeSH term(s) Antigen Presentation/physiology ; Antigens/physiology ; Antigens, Viral/immunology ; Autophagy/immunology ; CD4-Positive T-Lymphocytes/physiology ; Epstein-Barr Virus Nuclear Antigens/immunology ; Genes, MHC Class II/physiology ; Herpesvirus 4, Human/immunology ; Humans ; Viral Proteins/immunology
    Chemical Substances Antigens ; Antigens, Viral ; EBNA-2 protein, Human herpesvirus 4 ; EBNA-3C, epstein-barr virus ; Epstein-Barr Virus Nuclear Antigens ; Viral Proteins ; EBV-encoded nuclear antigen 1 (O5GA75RST7)
    Language English
    Publishing date 2007-01-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review ; Comment
    ZDB-ID 2454135-7
    ISSN 1554-8635 ; 1554-8627
    ISSN (online) 1554-8635
    ISSN 1554-8627
    DOI 10.4161/auto.3425
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Immune defence against EBV and EBV-associated disease.

    Long, Heather M / Taylor, Graham S / Rickinson, Alan B

    Current opinion in immunology

    2011  Volume 23, Issue 2, Page(s) 258–264

    Abstract: Epstein-Barr virus (EBV), a B-lymphotropic herpesvirus widespread in the human population and normally contained as an asymptomatic infection by T cell surveillance, nevertheless causes infectious mononucleosis and is strongly linked to several types of ... ...

    Abstract Epstein-Barr virus (EBV), a B-lymphotropic herpesvirus widespread in the human population and normally contained as an asymptomatic infection by T cell surveillance, nevertheless causes infectious mononucleosis and is strongly linked to several types of human cancer. Here we describe new findings on the range of cellular immune responses induced by EBV infection, on viral strategies to evade those responses and on the links between HLA gene loci and EBV-induced disease. The success of adoptive T cell therapy for EBV-driven post-transplant lymphoproliferative disease is stimulating efforts to target other EBV-associated tumours by immunotherapeutic means, and has reawakened interest in the ultimate intervention strategy, a prophylactic EBV vaccine.
    MeSH term(s) Animals ; Epstein-Barr Virus Infections/immunology ; Herpesvirus 4, Human/immunology ; Histocompatibility Antigens/genetics ; Histocompatibility Antigens/immunology ; Humans ; Neoplasms/immunology ; Neoplasms/therapy ; T-Lymphocytes/immunology ; Virus Internalization
    Chemical Substances Histocompatibility Antigens
    Language English
    Publishing date 2011-01-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1035767-1
    ISSN 1879-0372 ; 0952-7915
    ISSN (online) 1879-0372
    ISSN 0952-7915
    DOI 10.1016/j.coi.2010.12.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The immunology of Epstein-Barr virus-induced disease.

    Taylor, Graham S / Long, Heather M / Brooks, Jill M / Rickinson, Alan B / Hislop, Andrew D

    Annual review of immunology

    2015  Volume 33, Page(s) 787–821

    Abstract: Epstein-Barr virus (EBV) is usually acquired silently early in life and carried thereafter as an asymptomatic infection of the B lymphoid system. However, many circumstances disturb the delicate EBV-host balance and cause the virus to display its ... ...

    Abstract Epstein-Barr virus (EBV) is usually acquired silently early in life and carried thereafter as an asymptomatic infection of the B lymphoid system. However, many circumstances disturb the delicate EBV-host balance and cause the virus to display its pathogenic potential. Thus, primary infection in adolescence can manifest as infectious mononucleosis (IM), as a fatal illness that magnifies the immunopathology of IM in boys with the X-linked lymphoproliferative disease trait, and as a chronic active disease leading to life-threatening hemophagocytosis in rare cases of T or natural killer (NK) cell infection. Patients with primary immunodeficiencies affecting the NK and/or T cell systems, as well as immunosuppressed transplant recipients, handle EBV infections poorly, and many are at increased risk of virus-driven B-lymphoproliferative disease. By contrast, a range of other EBV-positive malignancies of lymphoid or epithelial origin arise in individuals with seemingly intact immune systems through mechanisms that remain to be understood.
    MeSH term(s) Adaptive Immunity ; Animals ; Carrier State ; Epstein-Barr Virus Infections/complications ; Epstein-Barr Virus Infections/diagnosis ; Epstein-Barr Virus Infections/immunology ; Epstein-Barr Virus Infections/virology ; Herpesvirus 4, Human/immunology ; Herpesvirus 4, Human/physiology ; Humans ; Immunity, Innate ; Immunocompromised Host ; Immunologic Deficiency Syndromes/etiology ; Lymphoproliferative Disorders/etiology
    Language English
    Publishing date 2015-02-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 604953-9
    ISSN 1545-3278 ; 0732-0582
    ISSN (online) 1545-3278
    ISSN 0732-0582
    DOI 10.1146/annurev-immunol-032414-112326
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top